726 related articles for article (PubMed ID: 35132597)
1. Potential Drug Strategies to Target Coronaviruses.
Sarkar K; Sil PC
Adv Exp Med Biol; 2021; 1352():111-124. PubMed ID: 35132597
[TBL] [Abstract][Full Text] [Related]
2. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
3. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
4. Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.
Tarique M; Ahmad S; Malik A; Ahmad I; Saeed M; Almatroudi A; Qadah T; Murad MA; Mashraqi M; Alam Q; Al-Saleh Y
Mol Cell Biochem; 2021 May; 476(5):2203-2217. PubMed ID: 33564990
[TBL] [Abstract][Full Text] [Related]
5. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
6. RNA Coronaviruses' Outbreaks: Recent Progress on the SARS-CoV-2 Pandemic Diagnostic Tests, Vaccination and Therapeutics.
Suaifan GARY; Alkhawaja BA; Mohammed AAM
Mini Rev Med Chem; 2022; 22(4):617-628. PubMed ID: 33888048
[TBL] [Abstract][Full Text] [Related]
7. Functional reconstitution of the MERS CoV receptor binding motif.
Uppalapati L; Roitburd-Berman A; Weiss-Ottolenghi Y; Graham BS; Dimitrov DS; Ying T; Failayev H; Tsfadia Y; Gershoni JM
Mol Immunol; 2022 May; 145():3-16. PubMed ID: 35272105
[TBL] [Abstract][Full Text] [Related]
8. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
[TBL] [Abstract][Full Text] [Related]
9. Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines.
Nascimento Júnior JAC; Santos AM; Cavalcante RCM; Quintans-Júnior LJ; Walker CIB; Borges LP; Frank LA; Serafini MR
Drug Dev Ind Pharm; 2021 Apr; 47(4):673-684. PubMed ID: 33826439
[TBL] [Abstract][Full Text] [Related]
10. Development of virus-like particles-based vaccines against coronaviruses.
Yong CY; Liew WPP; Ong HK; Poh CL
Biotechnol Prog; 2022 Nov; 38(6):e3292. PubMed ID: 35932092
[TBL] [Abstract][Full Text] [Related]
11. Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.
Sanguedolce F; Zanelli M; Froio E; Bisagni A; Zizzo M; Ascani S; Stallone G; Netti S; Ranieri E; Falagario U; Carrieri G; Cormio L
Crit Rev Clin Lab Sci; 2021 Dec; 58(8):563-575. PubMed ID: 34236278
[TBL] [Abstract][Full Text] [Related]
12. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
13. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection.
Costanzo M; De Giglio MAR; Roviello GN
Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment.
Kaur A; Bhalla V; Salahuddin M; Rahman SO; Pottoo FH
Curr Pharm Des; 2021; 27(33):3551-3565. PubMed ID: 33430745
[TBL] [Abstract][Full Text] [Related]
15. Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic.
Di Natale C; La Manna S; De Benedictis I; Brandi P; Marasco D
Front Pharmacol; 2020; 11():578382. PubMed ID: 33343349
[TBL] [Abstract][Full Text] [Related]
16. Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection.
Gutiérrez-Álvarez J; Honrubia JM; Fernández-Delgado R; Wang L; Castaño-Rodríguez C; Zúñiga S; Sola I; Enjuanes L
mBio; 2021 Mar; 12(2):. PubMed ID: 33653888
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.
Khan M; Adil SF; Alkhathlan HZ; Tahir MN; Saif S; Khan M; Khan ST
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374759
[TBL] [Abstract][Full Text] [Related]
18. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
Noor R
Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
[TBL] [Abstract][Full Text] [Related]
19. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.
Wu YH; Yeh IJ; Phan NN; Yen MC; Hung JH; Chiao CC; Chen CF; Sun Z; Hsu HP; Wang CY; Lai MD
J Microbiol Immunol Infect; 2021 Oct; 54(5):845-857. PubMed ID: 34176764
[TBL] [Abstract][Full Text] [Related]
20. Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.
Huang T; Sun L; Kang D; Poongavanam V; Liu X; Zhan P; Menéndez-Arias L
Adv Exp Med Biol; 2021; 1322():219-260. PubMed ID: 34258743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
